References
- Brassard M, AinMelk Y, Baillargeon JP. Basic infertility including polycystic ovary syndrome. Med Clin North Am 2008;92:1163–92, xi.
- Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil Steril 2012;97:28–38.e25.
- Balen, AH., Morley, LC., Misso, M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016;22:687–708.
- Kollmann, M., Martins, W. P., Lima, M. L. S., et al. Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2016;48:709–18.
- Xiao, J, Chen, S, Zhang, C, et al. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis. Gynecol Endocrinol 2013;29:187–91.
- Onofriescu, A, Bors, A, Luca, A, et al. GnRH antagonist IVF protocol in PCOS. Curr Health Sci J 2013;39:20–5.
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7.
- Alexiou E, Hatziagelaki E, Pergialiotis V, et al. Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index. Horm Mol Biol Clin Investig 2017;29:105–11.
- Gaddas M, Chaouache N, Ajina M, et al. Does hyperandrogenic statute in the polycystic ovary syndrome constitutes an obstacle to the success of in vitro fertilization? J Gynecol Obstet Biol Reprod (Paris) 2016;45:1091–8.
- Abide YC, Ozkaya E, Kayatas Eser S, et al. Association of basal serum androgen levels with ovarian response and ICSI cycle outcome. Ir J Med Sci 2017 [July 25]. doi: 10.1007/s11845-017-1665-1. [Epub ahead of print].
- Ramezanali F, Ashrafi M, Hemat M, et al. Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Mullerian hormone. Reprod Biomed Online 2016;32:503–12.
- Li M, Song J, Chen SL, et al. [Association of the clinical characteristics and the IVF-ET outcome in infertile women with polycystic ovarian syndrome of different subtypes]. Nan Fang Yi Ke Da Xue Xue Bao 2009;29:224–7.
- Banu J, Fatima P, Sultana P, et al. Association of infertile patients having polycystic ovarian syndrome with recurrent miscarriage. Mymensingh Med J 2014;23:770–3.
- Cocksedge KA, Li TC, Saravelos, SH, et al. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online 2008;17:151–60.
- van der Spuy ZM, Dyer SJ. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:755–71.
- Nekoonam S, Naji M, Nashtaei MS, et al. Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients. Arch Gynecol Obstet 2017;295:1041–50.
- Watson H, Franks S, Bonney RC. Regulation of epidermal growth factor receptor by androgens in human endometrial cells in culture. Hum Reprod 1998;13:2585–91.
- Cermik D, Selam B, Taylor HS. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:238–43.
- Freis A, Renke T, Kämmerer U, et al. Effects of a hyperandrogenaemic state on the proliferation and decidualization potential in human endometrial stromal cells. Arch Gynecol Obstet 2017;295:1005–13.
- Rosenfield RL, Ehrmann DA. The pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 2016;37:467–520.